Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Flamenbaum W AU - Friedman R TI - Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new [ldquo]loop[rdquo] diuretic JA - Pharmacotherapy PY - 1982/// VL - 2 SP - 213 EP - 222 ER - TY - JOUR AU - Ramsay LE AU - McInnes GT AU - Hettiarachi J AU - Shelton J AU - Scott P TI - Bumetanide and frusemide: A comparison of dose-response curves in healthy men JA - Br J Clin Pharmacol PY - 1978/// VL - 5 SP - 243 EP - 247 ER - TY - JOUR AU - Brater DC TI - Resistance to diuretics: Emphasis on a pharmacological perspective JA - Drugs PY - 1981/// VL - 22 SP - 477 EP - 494 ER - TY - JOUR AU - Dixon WR AU - Young RL AU - Holazo A AU - Jack ML AU - Weinfeld RE AU - Alexander K AU - Liebman A AU - Kaplan SA TI - Bumetanide: Radioimmunoassay and pharmacokinetic profile in humans JA - J Pharm Sci PY - 1976/// VL - 65 SP - 701 EP - 704 ER - TY - JOUR AU - Marcantonio LA AU - Auld WHR TI - Determination of the diuretic bumetanide in biological fluids by high-performance liquid chromatography JA - J Chromatogr PY - 1980/// VL - 183 SP - 118 EP - 123 ER - TY - JOUR AU - Brater DC AU - Seiwell R AU - Anderson S AU - Burdette A AU - Dehmer GJ AU - Chennavasin P TI - Absorption and disposition of furosemide in congestive heart failure JA - Kidney Int PY - 1982/// VL - 22 SP - 171 EP - 176 ER - TY - JOUR AU - Chennavasin P AU - Seiwell R AU - Brater DC AU - Liang WMM TI - Pharmacodynamic analysis of the furosemide-probenecid interaction in man JA - Kidney Int PY - 1979/// VL - 16 SP - 187 EP - 195 ER - TY - JOUR AU - Chennavasin P AU - Seiwell R AU - Brater DC TI - Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man JA - J Pharmacol Exp Ther PY - 1980/// VL - 215 SP - 77 EP - 81 ER - TY - JOUR AU - Smith DE AU - Lin ET AU - Benet LZ TI - Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay JA - Drug Metab Dispos PY - 1980/// VL - 8 SP - 337 EP - 342 ER - TY - GEN AU - Gibaldi M AU - Perrier D TI - JA - Pharmacokinetics PY - 1975/// VL - SP - EP - ER - TY - JOUR AU - Sedman AJ AU - Wagner JG TI - CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates JA - J Pharm Sci PY - 1976/// VL - 65 SP - 1006 EP - 1010 M3 - 10.1002/jps.2600650713 N1 - 10.1002/jps.2600650713 UR - http://dx.doi.org/10.1002/jps.2600650713 ER - TY - JOUR AU - Metzler CM AU - Elfring GL AU - McEwan AJ TI - A package of computer programs for pharmacokinetic modeling JA - Biometrics PY - 1974/// VL - 30 SP - 562 EP - ER - TY - JOUR AU - Boxenbaum HG AU - Riegelman S AU - Elashoff RM TI - Statistical estimations in pharmacokinetics JA - J Pharmacokinet Biopharm PY - 1974/// VL - 2 SP - 123 EP - 148 M3 - 10.1007/BF01061504 N1 - 10.1007/BF01061504 UR - http://dx.doi.org/10.1007/BF01061504 ER - TY - JOUR AU - Brater DC AU - Chennavasin P AU - Day B AU - Burdette A AU - Anderson S TI - Bumetanide and furosemide JA - Clin Pharmacol Ther PY - 1983/// VL - 34 SP - 207 EP - 213 ER - TY - JOUR AU - Odlind B TI - Relation between renal tubular secretion and effects of five loop diuretics JA - J Pharmacol Exp Ther PY - 1979/// VL - 211 SP - 238 EP - 244 ER - TY - JOUR AU - Kaojarern S AU - Day B AU - Brater DC TI - The time course of delivery of furosemide into urine is an independent determinant of overall response JA - Kidney Int PY - 1982/// VL - 22 SP - 69 EP - 74 ER - TY - JOUR AU - Davies DL AU - Lant AF AU - Millard NR AU - Smith AJ AU - Ward JW AU - Wilson GM TI - Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide JA - Clin Pharmacol Ther PY - 1974/// VL - 15 SP - 141 EP - 155 ER - TY - JOUR AU - Pentikainin PJ AU - Penttila A AU - Neuvonen PJ AU - Gothoni G TI - Fate of [14C]-bumetanide in man JA - Br J Clin Pharmacol PY - 1977/// VL - 4 SP - 39 EP - 44 ER - TY - JOUR AU - Pentikainen PJ AU - Nuevonen PJ AU - Kekki M AU - Penttila A TI - Pharmacokinetics of intravenously administered bumetanide in man JA - J Pharmacokinet Biopharm PY - 1980/// VL - 8 SP - 219 EP - 228 ER - TY - JOUR AU - Cutler RE AU - Blair AD TI - Clinical pharmacokinetics of furosemide JA - Clin Pharmacokinet PY - 1979/// VL - 4 SP - 279 EP - 296 ER - TY - JOUR AU - Benet LZ TI - Pharmacokinetics//pharmacodynamics of furosemide in man: A review JA - J Pharmacokinet Biopharm PY - 1979/// VL - 7 SP - 1 EP - 27 ER - TY - JOUR AU - Rose HJ AU - O'Malley K AU - Pruitt AW TI - Depression of renal clearance of furosemide in man by azotemia JA - Clin Pharmacol Ther PY - 1976/// VL - 1 SP - 141 EP - 146 ER - TY - JOUR AU - Andreasen F AU - Hansen HE AU - Mikkelsen E TI - Pharmacokinetics of furosemide in anephric patients and in normal subjects JA - Eur J Clin Pharmacol PY - 1978/// VL - 13 SP - 41 EP - 48 ER - TY - JOUR AU - Beermann B AU - Dalen E AU - Lindstrom B TI - Elimination of furosemide in healthy subjects and in those with renal failure JA - Clin Pharmacol Ther PY - 1977/// VL - 2 SP - 70 EP - 78 ER - TY - JOUR AU - Cutler RE AU - Forrey AW AU - Christopher TG AU - Kimpel BM TI - Pharmacokinetics of furosemide in normal subjects and functionally anephric patients JA - Clin Pharmacol Ther PY - 1974/// VL - 15 SP - 588 EP - 596 ER - TY - JOUR AU - Rane A AU - Villeneuve JP AU - Stone WJ AU - Nies AS AU - Wilkinson GR AU - Branch RA TI - Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia JA - Clin Pharmacol Ther PY - 1978/// VL - 24 SP - 199 EP - 207 ER - TY - JOUR AU - Tilstone WJ AU - Fine A TI - Furosemide kinetics in renal failure JA - Clin Pharmacol Ther PY - 1978/// VL - 23 SP - 644 EP - 650 ER - TY - JOUR AU - Brater DC AU - Chennavasin P AU - Seiwell R TI - Furosemide in patients with heart failure. Shift of the dose-response relationship JA - Clin Pharmacol Ther PY - 1980/// VL - 28 SP - 182 EP - 186 ER - TY - GEN AU - Benet LZ AU - Greither A AU - Meister W TI - Gastrointestinal absorption of drugs in patients with cardiac failure JA - The Effect of Disease States on Pharmacokinetics of Drugs PY - 1976/// VL - SP - 33 EP - 50 ER - TY - JOUR AU - Brater DC TI - Pharmacodynamic considerations in the use of diuretics JA - Annu Rev Pharmacol Toxicol PY - 1983/// VL - 23 SP - 45 EP - 62 M3 - 10.1146/annurev.pa.23.040183.000401 N1 - 10.1146/annurev.pa.23.040183.000401 UR - http://dx.doi.org/10.1146/annurev.pa.23.040183.000401 ER -